Wednesday, May 7, 2025

Latest

Vireo Health: Canaccord Lowers Revenue Estimates, Reiterates Price Target

Vireo Health (CSE: VREO) reported its second-quarter financials’ on August 26th, indicating revenue for the period was $12.2 million, a 70% year over year increase. Retail revenue was $9.2 million, a 46% increase year over year and was attributed to greater patient enrollment and higher average revenue per person. Wholesale revenue was $1.6 million, or a 256% increase year over year.

There are only three analysts who cover Vireo Health. Eight Capital increased their 12-month price target to C$1.50 from C$1 and raised their rating to buy from a hold rating prior, while Canaccord reiterated their C$2 price target and speculative buy rating. M Partners, who has the lowest price target of C$1.25, also reiterated their buy rating this morning. The average 12-month price target is C$1.58 or a 103% increase.

In Canaccord’s note, analyst Matt Bottomley headlines “Q2/20 review: A relatively flat quarter as VREO continues to shift to core markets.” Vireo’s revenue came in just below Bottomley’s estimate of $13.2 million, while even though gross margins increased to 29%, they still fell short of the 31% estimate. Management noted that they will be investing in their core markets further, for which Bottomley says will gradually get gross margins to over 40%.

Although Canaccord says that Pennsylvania is one of the more attractive medical markets, Vireo selling their cultivation and production assets for ~U$37 million, with an 18-month option to purchase Vireo’s Pennsylvania retail assets for another U$5 million in cash, “was much needed and should allow VREO to continue building out its presence in its other core markets.” With this cash infusion, Bottomley believes Vireo has enough cash to reach their management’s current objectives.

Turning the focus to Vireo’s five remaining core markets of Minnesota, New York, Maryland, and New Mexico, the analyst states that this mix of assets, “still have attractive optionality and upside.” Vireo’s management states they will be putting another $8-$9 million into these operations till the end of the year to reaccelerate their top line and work towards being cash flow positive by the second half of 2021.

Although Bottomley did not change Canaccord’s price target or rating, he slightly changed his full year 2020 forecasts. The firm now forecasts revenue and adjusted EBITDA to come in at $47.5 million and -$6 million, respectively, versus the prior estimate of $51.4 million and -$5 million.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

Giant Mining Encounters Native Copper As Hole MHB-34 Hits 563 Metres Depth

Verses Hits Commercialization Stage With Genius AI Platform

Related News

BMO Lifts Nuvei Price Target To $114

On November 9th, Nuvei Corporation (TSX: NVEI) announced its third quarter financial results. The company...

Wednesday, November 17, 2021, 03:05:00 PM

Air Canada: BMO Reinstates Coverage With $33 Price Target

Last week, BMO Capital Markets reinstated their coverage on Air Canada (TSX: AC) after discontinuing...

Saturday, March 6, 2021, 10:17:00 AM

Eguana Tech: Raymond James Initiates With $0.75 Price Target

On February 17th, Eguana Technologies (TSXV: EGT) saw a second analyst begin covering the stock,...

Tuesday, February 22, 2022, 12:22:00 PM

Walt Disney: Analysts Anticipate $15.87 Billion In Q2 Revenue

Walt Disney (NYSE: DIS) will be reporting their fiscal second-quarter financial results today after market...

Thursday, May 13, 2021, 02:20:00 PM

Kirkland Lake: Canaccord Maintains $68 Price Target, Buy Rating

On Wednesday, July 1, during market hours Kirkland Lake Gold (TSX: KL) reissued it’s 2020...

Thursday, July 2, 2020, 12:12:07 PM